hydrogen sulphide-releasing derivative of naproxen (ATB-346) - Antibe
https://www.businesswire.com/news/home/20190725005938/en/Antibe-Therapeutics-Announces-Size-Offering
 
Jul 25, 2019
 
Prev Next